Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Additive hazards model"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
A comparison of breast cancer survival among young, middle-aged, and elderly patients in southern Iran using Cox and empirical Bayesian additive hazard models
Samane Nematolahi, Seyyed Mohammad Taghi Ayatollahi
Epidemiol Health. 2017;39:e2017043.   Published online October 16, 2017
DOI: https://doi.org/10.4178/epih.e2017043
  • 10,722 View
  • 205 Download
  • 6 Web of Science
  • 5 Crossref
AbstractAbstract PDF
Abstract
OBJECTIVES
A survival analysis of breast cancer patients in southern Iran according to age has yet to be conducted. This study aimed to quantify the factors contributing to a poor prognosis, using Cox and empirical Bayesian additive hazard (EBAH) models, among young (20-39 years), middle-aged (40-64 years), and elderly (≥ 65 years) women.
METHODS
Data from 1,574 breast cancer patients diagnosed from 2002 to 2012 in the cancer registry of Fars Province (southern Iran) were stratified into 3 age groups. The Kaplan-Meier method was used to estimate the overall survival rates. Cox and EBAH models were applied to each age category, and the Akaike information criterion was used to assess the goodness-of-fit of the 2 hazard models.
RESULTS
As of December 2012, 212 women (13.5%) in our study population had died, of whom 43 were young (15.3%), 134 middle-aged (11.8%), and 35 elderly (22.3%). The 5-year survival probability by age category was 0.83 (standard error [SE], 0.03), 0.88 (SE, 0.01), and 0.75 (SE, 0.04), respectively.
CONCLUSIONS
The Nottingham Prognostic Index was the most effective prognostic factor. The model based on Bayesian methodology performed better with various sample sizes than the Cox model, which is the most widely used method of survival analysis.
Summary

Citations

Citations to this article as recorded by  
  • The health literacy level and its related factors in Iranian women with breast cancer undergoing chemotherapy
    Reyhaneh Sadeghian, Mahsa Asadollahi Hamedani, Sajad Salehipour, Anahita Sarabandi, Fatemeh Kiani, Hassan Babamohamadi
    Frontiers in Public Health.2023;[Epub]     CrossRef
  • sHLA-G as a biomarker for colorectal cancer pathogenesis
    Sabrine Dhouioui, Nadia Boujelbene, Hanen Chelbi, Ines Zemni, Ines Ben Safta, Hadda-Imene Ouzari, Amel Mezlini, Abdel Halim Harrath, Vera Rebmann, Inès Zidi
    Journal of King Saud University - Science.2022; 34(1): 101708.     CrossRef
  • Geo-epidemiological reporting and spatial clustering of the 10 most prevalent cancers in Iran
    Ebrahim Babaee, Gholamreza Roshandel, Meysam Olfatifar, Arash Tehrani-Banihashemi, Arezou Ashaari, Marzieh Nojomi
    Geospatial Health.2021;[Epub]     CrossRef
  • BREAST CANCER IN WESTERN KAZAKHSTAN: INCIDENCE, MORTALITY AND FACTORS ASSOCIATED WITH SURVIVAL
    Marzhan A. Aitmagambetova, Yerbol Zh. Bekmukhambetov, Gaziza A. Smagulova, Anar B. Tulyayeva, Arip K. Koyshybaev, Andrey M. Grjibovski
    Ekologiya cheloveka (Human Ecology).2021; 28(7): 51.     CrossRef
  • Validation of the 8th edition of the American Joint Committee on Cancer Pathological Prognostic Staging for young breast cancer patients
    Juan Zhou, Jian Lei, Jun Wang, Chen-Lu Lian, Li Hua, Li-Chao Yang, San-Gang Wu
    Aging.2020; 12(8): 7549.     CrossRef

Epidemiol Health : Epidemiology and Health